Targeted Oncology · 2024 · 15 citations · 13 references
MedicineOncologyPharmacologyCancer ImmunologyImmunotherapyMedical OncologyCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint ModulationImmune Checkpoint RegulationTargeted Cancer TherapyAtezolizumab TherapyDurvalumab TherapyImmune Checkpoint Inhibitor Therapy
13
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn, Shukui Qin, Masafumi Ikeda et al. · New England Journal of Medicine · 2020 · 7.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +12
Management of Hepatocellular Carcinoma *
Jordi Bruix, Morris Sherman · Hepatology · 2005 · 5.9K citations · Full text
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Josep M. Llovet, Andrew K. Burroughs, Jordi Bruix · The Lancet · 2003 · 3.6K citations
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo et al. · NEJM Evidence · 2022 · 1.4K citations · Full text
Medicine, Oncology, Pharmacotherapy +16